Kurtzke JF. MS epidemiology worldwide: one view of current status. Acta Neurol Scand Suppl 1995; 161:23-33.

Riise T, Gronning M, Klauber MR, et al. Clustering of residence of multiple sclerosis patients at age 13 to 20 years in Hordaland, Norway. Am J Epidemiol 1991; 133:932-939. Munch M, Hvas J, Christensen T, et al. A single subtype of Epstein Barr virus in members of multiple sclerosis clusters. Acta Neurol Scand 1998; 98:395-399. MacGregor HS, Latiwonk QI. Is multiple sclerosis an autoimmune disease or a chronic gammaherpes virus infection? J Clin Lab Immunol 1996; 48:45-74.

80. Bray PF, Culp KW, McFarlin DE, et al. Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection. Neurology 1992; 42:278-282.

81. Richardson JR. Demyelinating disease association with Epstein-Barr virus. Arch Neurol 1984; 41:14-15.

82. Adams JM. Demyelinating diseases and certain virus infections. Pathobiol Annu 1972; 2:183-205.

83. Alotaibi S, Kennedy J, Tellier R, et al. Epstein-Barr virus in pediatric multiple sclerosis. JAMA 2004; 291:1875-1879.

84. Sumaya CV, Myers LW, Ellison GW, Ench Y. Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis. Ann Neurol 1985; 17:371-377.

85. Larsen PD, Bloomer LC, Bray PF. Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis. Neurology 1985; 35:435-438.

86. Compston DA, Vakarelis BN, Paul E, et al. Viral infection in patients with multiple sclerosis and HLA-DR matched controls. Brain 1986; 109(Pt 2):325-344.

87. Sumaya CV, Myers L, Ellison GW. Epstein-Barr virus antibodies in multiple sclerosis. Trans Am Neurol Assoc 1976; 101:300-302.

88. Bray PF, Bloomer LC, Salmon VC, et al. Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis. Arch Neurol 1983; 40:406-408.

89. Myhr KM, Riise T, Barrett-Connor E, et al. Altered antibody pattern to Epstein-Barr virus but not to other herpes viruses in multiple sclerosis: a population based case-control study from western Norway. J Neurol Neurosurg Psychiatry 1998; 64:539-542.

90. Munch M, Riisom K, Christensen T, et al. The significance of Epstein-Barr virus seropositivity in multiple sclerosis patients? Acta Neurol Scand 1998; 97:171-174.

91. Pender MP. Infection ofautoreactive B-lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol 2003; 24:584-588.

92. Ascherio A, Munger KL, Lennette ET, et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 2001; 286:3083-3088.

93. Levin LI, Munger KL, Rubertone MV, et al. Multiple sclerosis and Epstein-Barr virus. JAMA 2003; 289:1533-1536.

94. Wandinger K, Jabs W, Siekhaus A, et al. Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 2000; 55:178-184.

95. Bray PF, Luka J, Bray PF, et al. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology 1992; 42:1798-1804.

96. Rand KH, Houck H, Denslow ND, Heilman KM. Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis. J Neurol Sci 2000; 173:32-39.

97. Hilton DA, Love S, Fletcher A, Pringle JH. Absence of Epstein-Barr virus RNA in multiple sclerosis as assessed by in situ hybridisation. J Neurol Neurosurg Psychiatry 1994; 57:975-976.

98. Morre SA, van Beek J, DeGroot CJ, et al. Is Epstein-Barr virus present in the CNS of patients with MS? Neurology 2001; 56:692.

99. Martin C, Enbom M, Soderstrom M, et al. Absence of seven human herpes viruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis. Acta Neurol Scand 1997; 95:280-283.

100. Clausen J. Endogenous retroviruses and MS: using ERVs as disease markers. The International MS Journal 2003; 10:22-28.

101. Garson JA. Commentary on J Clausen's review—endogenous retroviruses in MS. The International MS Journal 2003; 10:20-21.

102. Koprowski H, DeFreitas EC, Harper ME, et al. Multiple sclerosis and human T-cell lymphotropic retroviruses. Nature 1985; 318:154-160.

Rasmussen HB, Perron H, Clausen J. Do endogenous retroviruses have etiologic implications in inflammatory and degenerative nervous system diseases? Acta Neurol Scand 1993; 88:190-198.

Perron H, Geny C, Laurent A, et al. Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res Virol 1989; 140:551-561. Perron H, Garson JA, Bedin F, et al. The collaborative research group on multiple sclerosis. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc Natl Acad Sci USA 1997; 94:7583-7588.. Greenberg SJ, Ehrlich GD, Abbott MA, Hurwitz BJ, Waldmann TA, Poiesz BJ. Detection of sequences homologous to human retroviral DNA in multiple sclerosis by gene amplification. Proc Natl Acad Sci USA 1989; 86:2878-2882.

Perron H, Gaerson JA, Bedin F, et al. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc Natl Acad Sci USA 1997; 94:7583-7588.

Hackett J, Swanson P, Leahy D, et al. Search for retrovirus in patients with multiple sclerosis. Ann Neurol 1996; 40:805-809.

Clerici M, Fusi ML, Caputo D, et al. Immune response to antigens of human endogenous retroviruses in patients with acute or stable multiple sclerosis. J Neuroimmunol 1999; 99:173-182.

Kolson DL. Endogenous retroviruses and multiple sclerosis. Ann Neurol 2001; 50: 429-430.

Meinl E. Concepts of viral pathogenesis of multiple sclerosis [review]. Curr Opin Neurol 1999; 12(3):303-307.

Dolei A, Serra C, Mameli G, et al. Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients. Neurology 2002; 58:471-473.

Wilborn F, Schmidt CA, Brinkmann V, Jendroska K, Oettle H, Siegert W. A potential role for human herpes virus type 6 in nervous system disease. J Neurolmmunol 1994; 49:213-214.

Sola P, Merelli E, Marasca R, et al. Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodiies by immunofluorescence analysis and of viral sequences by polymerase chain reaction. J Neurol Neurosurg Psychiatry 1993; 56:917-919. Saito Y, Sharer LR, Dewhurst S, Blumberg BM, Hall CB, Epstein LG. Cellular localization of human herpes virus-6 in the brains of children with AIDS encephalopathy. J Neurovirol 1995; 1:30-39.

Asano Y, Yoshikawa T, Kajita Y, et al. Fatal encephalitis/encephalopathy in primary human herpesvirus-6 infection. Arch Dis Child 1992; 67:1484-1485. Novoa LJ, Nagra RM, Nakawatase T, Edwards-Lee T, Tourtellotte WW, Cornford ME. Fulminant demyelinating encephalomyelitis associated with productive HHV-6 infection in an immunocompetent adult. J Med Virol 1997; 52:301-308.

Merelli E, Sola P. Barozzi P, Torelli G. An encephalitic episode in a multiple sclerosis patient with human herpesvirus 6 latent infection. J Neurol Sci 1996; 137:42-46. Carrigan DR, Harrington D, Knox KK. Subacute leukoencephalitis caused by CNS infection with human herpesvirus-6 manifesting as acute multiple sclerosis. Neurology 1996; 47:145-148.

Kamei A, Ichinohe S, Onuma R, Hiraga S, Fujiwara T. Acute disseminated demyelina-tion due to primary human herpesvirus-6 infection. Eur J Pediatr 1997; 156:709-712. Bergstrom T. Herpesviruses-A rational for antiviral treatment in multiple sclerosis. Antivir Res 1999; 41:1-19.

Mackenzie IRA, Carrigan DR, Wiley CA. Chronic myelopathy associated with human herpesvirus-6. Neurology 1995; 45:2015-2017.

Knox KK, Harrington D, Carrigan DR. Active human herpesvirus type 6 infections are present in the central nervous system, lymphoid tissues and peripheral blood of patients with multiple sclerosis. Ann Neurol 1998; 44:485.

124. Mirandola P, Stefan A, Brambilla E, et al. Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients. Neurology 1999; 53:1367-1368.

125. Taus C, Pucci E, Cartechini E, et al. Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis. Acta Neurol Scand 2000; 101:224-228.

126. Al-Shammari S, Nelson RF, Voevodin A. HHV-6 DNAaemia in patients with multiple sclerosis in Kuwait. Acta Neurol Scand 2003; 107:122-124.

127. Sanders VJ, Waddell AE, Felisan SL, Li X, Comad AJ, Tourtellotte WW. Herpes simplex virus in postmortem multiple sclerosis brain tissue. Arch neurol 1996; 53:125.

128. Gordon L, Mcquaid S, Cosby SL. Detection of herpes simplex virus (types 1 and 2) and human herpesvirus 6 DNA in human brain tissue by polymerase chain reaction. Clin Diagn Virol 1996; 6(l):33-40.

129. Dowling P, Husar W, Menonna J, Donnenfeld H, Cook SD, Sidhu M. Cell death and birth in multiple sclerosis brain. J Neurol Sci 1997; 149:1-11.

130. Brahic M, Bureau JF. Multiple sclerosis and retroviruses [letter]. Ann Neurol 1997; 42:984-985.

131. Ablashi DV, Lapps W, Kaplan M, et al. Human herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report. Mult Scler 1998; 4:490-496.

132. Soldan SS, Berti R, Salem N, et al. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nature Med 1997; 3:1994-1997.

133. Kim JS, Park JH, Lee KH, Lee KS, Shin WS. Detection of human herpes virus 6 variant a sequence in multiple sclerosis. Neurology 1999; 52(suppl 2):A491.

134. Goldberg SH, Albright AV, Lisak RP, Gonzalez-Scarano F. Polymerase chain reaction analysis of human herpesvirus-6 sequences in the sera and cerebrospinal fluid of patients with multiple sclerosis. J Neurovirol 1999; 5:134-139.

135. Martin C, Enbom M, Soderstrom M, et al. Absence of seven human herpesviruses including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis. Acta Neurol Scand 1997; 95:280-283.

136. Ongradi J, Rajda C, Marodi CL, Csiszar A, Vecsci L. A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients. J Neurovirol 1999; 5:529-532.

137. Nielsen L, Larsen AM, Munk M, Vestergaard BF. Human herpesvirus-6 immunoglo-bulin G antibodies in patients with multiple sclerosis. Acta Neurol Scand 1997; 169(suppl):76-78.

138. Nielsen L, Mollerlarsen A, Munk M, Vestergaard BF. Human herpesvirus-6 immuno-globulin G antibodies in patients with multiple sclerosis. Acta Neurol Scand 1997; 95(suppl 169):76-78.

139. Fillet AM, Lozeron P, Agut H, et al. HHV-6 and multiple sclerosis [letter]. Nat Med 1998; 4:537.

140. Enbom M, Wang FZ, Fredrikson SL, et al. Similar humoral and cellular immunological reactivities to human herpesvirus 6 in patients with multiple sclerosis and controls. Clin Diagn Lab Immunol 1999; 6:545-549.

141. Stuve O, Racke M, Hemmer B. Viral pathogens in multiple sclerosis. Arch Neurol 2004; 61:1500-1502.

142. Soldan SS, Leist TP, Juhng KN, McFarland HF, Jacobson S. Increased lymphoproli-ferative response to human herpesvirus type 6A variant in multiple sclerosis patients. Ann Neurol 2000; 47:306-313.

143. Berti R, Brennan MB, Soldan SS, et al. Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression. J Neurovirol 2002; 8(3):250-256.

144. Alvarez-Lafuente R, De las Heras V, Bartolome M, Picazo JJ, Arroyo R. Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection. Arch Neurol 2004; 61:1523-1527.

Lycke J, Svennerholm B, Hjelmquist E, et al. Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled double-blind study. J Neurol 1996; 243:214-224.

Bech E, Lycke J, Gadeberg P, et al. A randomized double-blind placebo-controlled MRI study of anti-herpes virus therapy in MS. Neurology 2002; 58:31-36. Grayston JT, Campbell LA, Kuo CC, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990; 161:618-625. Danville T. Chlamydia. Pediatr Rev 1998; 19:85-91.

Shor A, Phillips JL. Chlamydia pneumoniae and athlerosclerosis. JAMA 1999; 282: 2071-2073.

Maass M, Gieffers J. Prominent serological response to Chlamydia pneumoniae in cardiovascular disease. Immunol Infect Dis 1996; 6:65-70.

Balin BJ, Gerard HC, Arking EJ, et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol 1998; 187:23-42. Nochlin D, Shaw CM, Campbell LA, Kuo CC. Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer's disease. Neurology 1999; 53:1888. Gieffers J, Reusche E, Solbach W, Maass M. Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer's disease patients (abstr). Clin Microbiol Infect 1999; 5(suppl 3):90.

Sriram S, Mitchell W, Stratton C. Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS. Neurology 1998; 50:571-572.

Yao SY, Sriram S, Nashville TN. Reactivity of oligoclonal bands seen in CSF to C. pneumoniae antigens in patients with multiple sclerosis. Neurology 1999; 52(suppl 2):A559. Munger KL, DeLorenze GN, Levin LI, et al. A prospective study of Chlamydia pneumoniae infection and risk of MS in two U.S. cohorts. Neurology 2004; 62:1799-1803. Kaufman M, Gaydos CA, Sriram S, Boman J, Tondella ML, Norton HJ. Is Chlamydia pneumonia found in spinal fluid samples from multiple sclerosis patients? Conflicting results. Mult Scler 2002; 8:289-294.

Layh-Schmitt G, Bendl C, Hildt U, et al. Evidence for infection with Chlamydia pneu-moniae in a subgroup of patients with multiple sclerosis. Ann Neurol 2000; 47:652-655. Poland SD, Rice GPA. Chlamydia pneumoniae and multiple sclerosis. Neurology 2000; 54(suppl 3):A165.

Boman J, Roblin PM, Sundstrom P, Sandstrom M, Hammerschlag MR. Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS. Neurology 2000; 54:265.

Appel MJG, Gillespie JH. Canine Distemper Virus. Vienna: Springer-Verlag IV, interactions with organism, 1972; 1153:26-34.

Maurer KC, Neilsen SW. Neurological disorders in the raccoon in northeastern United States. J Am Vet Med Assoc 1981; 179:1095-1098.

Vandevelde M, Higgins RJ, Kristensen B, Kristensen F, Steck A, Kihm U. Demyelina-tion in experimental canine distemper virus infection; immunological, pathologic and immunohistological studies. Acta Neuropathol (Berl) 1982; 56:285-293. Blythe LL, Schmidtz JA, Roelke M, et al. Chronic encephalomyelitis caused by canine distemper virus in a Bengal tiger. J Am Vet Med Assoc 1983; 183:1159-1162. Yoshikawa Y, Ochikubo F, Maatsubara Y, et al. Natural infection with canine distemper virus in a Japanese monkey. Vet Microbiol 1989; 20:193-205. Murray K, Selleck P, Hooper P, et al. A morbillivirus that caused fatal disease in horses and humans. Science 1995; 268:94-97.

Higgins RJ, Child G, Vandevelde M. Chronic relapsing demyelinating encephalomyeli-tis associated with persistent canine distemper virus infection. Acta Neuropathol 1989; 77:441-444.

Bansil S, Singhal BS, Ahuja GK, et al. Multiple sclerosis in India: a case control study of environmental exposures. Acta Neurol Scand 1997; 95:208-210.

169. Norman J, Cook SD, Dowling PC. Pilot survey of household pets among veterans with multiple sclerosis and age-matched controls. Arch Neurol 1983; 40:213-214.

170. Man, dogs and hydatid disease [editorial]. Lancet 1987; 1:21-22.

171. Cook SD, Dowling PC. A possible association between house pets and multiple sclerosis. Lancet 1977; 1:980-982.

172. Cook SD, Natelson BH, Levin BE, et al. Further evidence of a possible association between house dogs and multiple sclerosis. Ann Neurol 1978; 3:141-143.

173. Compston DAS, Vakarelis BN, Paul E, McDonald WI, Batchelor JR, Mims CA. Viral infections in patients with multiple sclerosis and HLA-DR matched controls. Brain 1986; 109:325-344.

174. Leibowitz U, Alter M. Multiple Sclerosis: Clues to Its Cause. Amsterdam: North-Holland, 1973.

175. Antonovsky A, Leibowitz U, Smith H, et al. Epidemiologic study of multiple sclerosis in Israel, part I (an overall review of methods and findings). Arch Neurol 1965; 13:183-193.

176. Jotkowitz S. Multiple sclerosis and exposure to house pets. JAMA 1977; 238:854.

177. Flodin U, Soderfeldt B, Noorlind-Brage H, Fredriksson M, Axelson O. Multiple sclerosis, solvents and pets: a case-referent study. Arch Neurol 1988; 45:620-623.

178. Landtblom AM, Flodin U, Karlsson M. Multiple sclerosis and exposure to solvents: ionizing radiation, and animals. Scand J Work Environ Health 1993; 19:399-404.

179. Antonovsky A, Leibowitz U, Medalie JM, et al. Reappraisal of possible aetological factors in multiple sclerosis. Am J Public Health 1968; 58:836-848.

180. Mititelu G, Cemescu C, Bourceanu R. Dog ownership among multiple sclerosis patients and their level of measles antibodies: a case control study. Rev Med Chir Soc Med Nat Iasi 1986; 90:673-677.

181. Granieri E, Casetta I, Tola MR. Epidemiology of multiple sclerosis in Italy and southern Europe. Acta Neural Scand Suppl 1995; 161:60-70.

182. Anderson LJ, Kibler RF, Kaslow RA, et al. Multiple sclerosis unrelated to dog exposure. Neurology 1984; 34:1149-1154.

183. Warren SA, Warren KG, Greenhill S, Paterson M. How multiple sclerosis is related to animal illness, stress and diabetes. Can Med Assoc J 1982; 126:377-385.

184. Read D, Nassim D, Smith P, Paterson C, Warlow C. Multiple sclerosis and dog ownership: a case-control investigation. J Neurol Sci 1982; 55:359-367.

185. Bauer HJ, Wikstrom J. Multiple sclerosis and house pets. Lancet 1878; 2:1029.

186. Hughes RAC, Russell WC, Froude JRL, Jarrett RJ. Pet ownership, distemper antibodies and multiple sclerosis. J Neural Sci 1980; 47:429-432.

187. Sidhu SS, Husar W, Cook SD, Dowling PC, Udem SA. Canine distemper terminal and intergenic non-protein coding nucleotide sequences: completion of the entire CDV genome. Virology 1993; 193:66-72.

188. Sidhu SS, Menonna JP, Cook SD, Dowling PC, Udem SA. Canine distemper virus L gene: sequence and comparison with related viruses. Virology 1993; 193:50-65.

189. Cook SD, Dowling PC, Russell WC. Neutralizing antibodies to canine distemper and measles virus in multiple sclerosis. J Neurol Sci 1979; 41:61-70.

190. Appel MJ, Glickman LI, Raine CS, et al. Viruses and multiple sclerosis. Neurology 1981; 31:944-949.

191. Rohowsky-Kochan C, Dowling PC, Cook SD. Canine distemper virus-specific antibodies in multiple sclerosis. Neurology 1995; 45:1554-1560.

192. Cook SD, Dowling PC, Prineas JW, et al. A radioimmunoassay search for measles and distemper antigens in subacute sclerosing panencephalitis and multiple sclerosis brain tissues. J Neurol Sci 1981; 51:447-456.

193. Hall WW, Choppin PW. Failure to detect measles virus proteins in brain tissue of patients with multiple sclerosis. Lancet 1982; 1:957.

194. Simini B. Measurement of posterior fossa neurovascular anomalies in essential hypertension [letter]. Lancet 1995; 345:131.

0 0

Post a comment